ClinicalTrialsFinder

ALK-positive Non-small Cell Lung Cancer (NSCLC) Clinical Trials in Bogotá

1 recruitingBogotá, Colombia

Showing 1–1 of 1 trials

Recruiting

Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib

Lung AdenocarcinomaDepressionCognitive Dysfunction+3 more
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo24 enrolled1 locationNCT07633626